Related Experiment Videos
Decitabine in myelodysplastic syndromes: viewpoints
Guillermo Garcia-Manero1, Hussain I Saba
1Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
Drugs
|June 3, 2006
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Minimal residual disease eradication with epigenetic therapy in core binding factor acute myeloid leukemia.
American journal of hematology·2017
Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents.
American journal of hematology·2017
An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes.
American journal of hematology·2017
Focal Adhesion Kinase as a Potential Target in AML and MDS.
Molecular cancer therapeutics·2017
Ecnoglutide: First Approvals.
Drugs·2026
Clinical characteristics, surgical management, and outcomes of uterine smooth muscle tumours of uncertain malignant potential: a single-centre experience.
Przeglad menopauzalny = Menopause review·2026
BCR-ABL1 Transcript Variants in Chronic Myeloid Leukemia Patients in Africa: A Systematic Review.
Health science reports·2026
Classical Hodgkin Lymphoma Today.
Mediterranean journal of hematology and infectious diseases·2026
LTF promotes central nervous system leukemia progression via neutrophil serine proteases.
Frontiers in pharmacology·2026